C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2011
06/07/2011	US7956075 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain.
06/07/2011	US7956071 Imidazole compounds
06/07/2011	US7956066 Imidazole compounds
06/07/2011	US7956060 Pyrimidine derivative compound
06/07/2011	US7956058 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
06/07/2011	US7956057 Imidazole compounds
06/07/2011	CA2562130C 2-propene-1-ones as hsp 70 inducers
06/07/2011	CA2551141C Derivatives of n-(1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
06/07/2011	CA2470515C Dna minor groove binding compounds
06/07/2011	CA2213759C Method for treating amyloidosis
06/03/2011	WO2011066184A1 Novel compounds as receptor modulators with therapeutic utility
06/03/2011	WO2011066183A1 Novel spiropiperidine compounds
06/03/2011	WO2011066179A1 Novel compounds as receptor modulators with therapeutic utility
06/03/2011	WO2011042473A3 Estrogen receptor ligands
06/03/2011	CA2781292A1 Novel spiropiperidine compounds
06/03/2011	CA2780987A1 Novel compounds as receptor modulators with therapeutic utility
06/03/2011	CA2780908A1 Novel compounds as receptor modulators with therapeutic utility
06/02/2011	US20110130431 Compounds Which Modulate The CB2 Receptor
06/02/2011	US20110130426 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
06/02/2011	US20110130407 Isoquinolinone derivatives as nk3 antagonists
06/02/2011	US20110130399 Phthalazine Derivatives with Angiogenesis Inhibiting Activity
06/02/2011	US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
06/02/2011	US20110130381 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
06/02/2011	US20110130380 Heteroaryl Kinase Inhibitors
06/02/2011	US20110129542 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1
06/02/2011	US20110127495 New compound and organic light emitting device using the same
06/01/2011	EP2327701A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
06/01/2011	EP2327700A1 Dialkyl triazinamines and use thereof for combating undesired plant growth
06/01/2011	EP2327699A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent
06/01/2011	EP2327693A1 Indoles and their therapeutic use
06/01/2011	EP2327692A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors
06/01/2011	EP2327690A1 Tricyclic compound
06/01/2011	EP2326640A1 Pyrrole carboxylic acid derivatives as antibacterial agents
06/01/2011	EP2326633A1 Compounds for the treatment of hepatitis c
06/01/2011	EP2326627A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
06/01/2011	EP2326625A1 Benzazepine derivatives and their use as hstamine h3 antagonists
06/01/2011	EP2326623A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
06/01/2011	EP2326622A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds
06/01/2011	EP2326175A2 Allosteric enhancers of the a1 adenosine receptor
06/01/2011	EP1981854B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/01/2011	EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers
06/01/2011	DE102010002558A1 Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe The use of physiological cooling agents and compositions comprising such agents
06/01/2011	CN1934103B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
06/01/2011	CN102083818A Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
06/01/2011	CN102083817A Compounds and compositions as ITPKB inhibitors
06/01/2011	CN102083797A Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
06/01/2011	CN102083794A Urea compounds as gamma secretase modulators
06/01/2011	CN102082230A Infrared organic electroluminescent device
06/01/2011	CN102079743A Dipeptidyl peptidase inhibitors
06/01/2011	CN101671331B Lipoyl vildagliptin as well as preparation method and application thereof
06/01/2011	CN101580503B Green synthesis method of furane derivative
06/01/2011	CN101475568B Di-polyindenothiophene derivatives and use thereof
06/01/2011	CN101189221B Ampa receptor potentiators
05/2011
05/31/2011	US7951972 Human adam-10 inhibitors
05/31/2011	US7951940 Substituted indole compounds having NOS inhibitory activity
05/31/2011	US7951830 Compounds effecting glucokinase
05/31/2011	US7951820 Triazole compounds useful as protein kinase inhibitors
05/31/2011	US7951809 Inhibitors of p38
05/31/2011	US7951808 Imidazole compounds
05/31/2011	US7951804 Inhibitors of coagulation factors; Thrombosis, tumors, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis; example, 1-(4-chlorophenyl)-3-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-phenylethyl]urea
05/31/2011	US7951803 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders
05/31/2011	US7951752 O-cyclopropyl-carboxanilides and their use as fungicides
05/31/2011	CA2507657C 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
05/31/2011	CA2475764C New inhibitors of histone deacetylase
05/26/2011	WO2011062194A1 Aminopyridine derivative
05/26/2011	WO2011061168A1 Aryl-pyridine derivatives as aldosterone synthase inhibitors
05/26/2011	WO2011061139A1 Substituted pyrrolidine-2-carboxamides
05/26/2011	WO2011060859A1 Materials for organic electroluminescent devices
05/26/2011	US20110124870 Novel mycobacterial inhibitors
05/26/2011	US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
05/26/2011	US20110124669 Modulators of Cellular Adhesion
05/26/2011	US20110124633 Heterocyclic Compounds, Methods of Making Them and Their Use in Therapy
05/26/2011	US20110124625 Modulators of Cellular Adhesion
05/26/2011	US20110122475 Photochromic dichroic naphtho-pyrans and optical articles containing them
05/26/2011	CA2778867A1 Substituted pyrrolidine-2-carboxamides
05/25/2011	EP2325279A2 Electroluminescent iridium compounds
05/25/2011	EP2325180A1 Chiral CIS-imidazolines
05/25/2011	EP2325179A1 Glycosidase ihhibitors and preparation thereof
05/25/2011	EP2325178A1 Process for production of optically active compound
05/25/2011	EP2325175A1 2,4-diaminopyrimidine compound
05/25/2011	EP2324015A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
05/25/2011	EP2324014A2 Silent desensitizers of neuronal nachr and methods of use thereof
05/25/2011	EP2324008A1 3,4-diarylpyrazoles as protein kinase inhibitors
05/25/2011	EP2324005A1 Novel methylenedioxy phenolic compounds and their use to treat disease
05/25/2011	EP2323993A2 2,6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
05/25/2011	EP2323992A1 5-alkynyl-pyrimidines
05/25/2011	EP2323988A1 Alpha7 nicotinic acetylcholine receptor inhibitors
05/25/2011	EP2323987A1 N-myristoyl transferase inhibitors
05/25/2011	EP2212297B1 Inhibitors of protein kinases
05/25/2011	EP2125748B1 Acylaminopyrazoles as fgfr inhibitors
05/25/2011	EP1868994B1 Sulfonylpyrroles as histone deacetylase inhibitors
05/25/2011	EP1863787B1 Hydogrenated benzo[c]thiophene derivatives as immunomodulators
05/25/2011	CN1863770B Cyclic amine BASE-1 inhibitors having a heterocyclic substituent
05/25/2011	CN1578663B Inhibitors of histone deacetylase
05/25/2011	CN102076681A Substituted gamma lactams as therapeutic agents
05/25/2011	CN102076678A Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors
05/25/2011	CN102076666A Aminopyridine derivatives
05/25/2011	CN102070624A Method for synthesizing tiagabine hydrochloride and method for preparing anhydrous tiagabine hydrochloride
05/25/2011	CN102070623A Barbituric acid derivatives and preparation method thereof
05/25/2011	CN102067838A Amide fragment-containing (Z) type nitenpyram analogue pesticide and preparation method thereof

1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 523